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Introduction
Oxygen (O 2 ) and iron are among the most abundant elements in the crust of the earth, oxygen being the first and iron being the fourth most common. Both elements have significant roles in human biology [1, 2] .
Iron is essential for oxygen transport and is a component of molecular O 2 -carrying proteins, such as hemoglobin and myoglobin. Iron is also a constituent of redox enzymes and can occupy multiple oxidation states [3] [4] [5] . Iron, as a transition metal, is involved in reduction-oxidation (redox) reactions, involving single electron transfer between its ferric (Fe (III)) and ferrous (Fe (II)) states [6] [7] [8] . The chemical character of iron explains not only its biological significance, but also its toxicity [9] . The ferrous form of free iron reacts in Fenton reactions with hydrogen peroxide to generate both hydroxyl radicals and higher oxidation states of the iron, which can cause biological damage, including damage to DNA, proteins, and lipids [10] . At the early stage of biological evolution, free-iron levels were high and an atmosphere full of oxygen had not yet developed. The photosynthesis by plants generated molecular O 2 , which reacted with free iron in the environment to form insoluble iron oxides. Fe (III) oxide or ferric oxide is an inorganic compound, with the formula Fe 2 O 3 . Initially, O 2 was toxic to living organisms; however, later, oxygen could be used as the terminal electron acceptor in energy-producing biochemical reactions, taking place in the mitochondria of each cell. Either deficiency or overload of iron or O 2 can be equally detrimental for living beings. An elaborate system has evolved to stringently regulate the concentrations of both, free iron and O 2, in various sites of the body. At the cellular level, where O 2 concentrations are usually low, free iron plays an important role in biological processes. The final destination for iron and O 2 in the cells is the mitochondria. The mitochondria require substantial amounts of iron for heme synthesis and maturation of iron-sulfur clusters, and oxygen as the electron acceptor in oxidative phosphorylation. Therefore, a good balance between the control of iron availability and the physiology of hypoxic responses is critical for maintaining cell homeostasis. Several lines of study have clearly demonstrated that the transcription factors, hypoxia-inducible factors (HIFs), play a central role in cellular adaptation to critically low oxygen levels, in both normal and compromised tissues. It has also been shown that several target genes of HIFs are involved in iron homeostasis, reflecting the molecular links between oxygen homeostasis and iron metabolism.
The total amount of iron in the body is 3-4 g and exists as heme iron, as a prosthetic molecule such as hemoglobin, myoglobin, in the electron transfer system, in metabolic enzymes and as stored iron in reticuloendothelial cells [7, 8, 11] . Approximately 70% of the total iron forms a part of hemoglobin, contained in red blood cells (RBCs) [11, 12] . Because RBCs have a lifespan of 120 days, 1/120 RBCs are treated and renewed daily. In humans, there is no active mechanism of iron excretion; only a small amount is excreted from the body as sweat and mucous membranes of detached epithelial cells [12] . Therefore, most of the iron in the body is replaced in-out on a daily basis; the treated erythrocyte-derived iron is recycled without being excreted [13] . Approximately 20-25 mg of iron is used for hemoglobin in new RBCs. Absorbed iron from the diet is 1-2 mg, whereas the remaining iron is derived from wasted and treated RBCs [14] . The iron absorbed from the intestinal tract and recycled iron from macrophages, bind to transferrin (Tf) and are transferred to the bone marrow, the site of erythrocyte hematopoiesis [15] . Tf-bound iron then binds to the Tf receptors, which are internalized into the cell. Following internalization, the iron is dissociated from Tf by low pH endosomes [8, 11] . The discharge of iron from the endosomes takes place via divalent metal transporter 1 [15] and this iron is then used for heme synthesis in the mitochondria (Fig. 1) .
In this review, I describe a paradigm of regulation for pathways that sense both iron and oxygen availability and coordinate the maintenance of mammalian iron and oxygen homeostasis, at both the cellular and systemic levels, especially from the point of view of HIFs.
Hypoxia-inducible factors (HIFs)

Systemic and cellular hypoxia-induced responses
Oxygen is an essential molecule for maintaining human life, particularly for cellular ATP production [16, 17] . Energy deficit due to oxygen deficiency makes it impossible to maintain biological functions. During oxidative phosphorylation in the mitochondria, a series of phosphorylation (ATP synthesis) reactions occurs in conjugation with the electron transfer system, where oxygen functions as a final receptor for electrons. This process, which involves a series of oxidation reactions of the conenzymes, NADH and FADH, and reduction reaction of oxygen molecule (O 2 ) to water molecule (H 2 O), is affected by oxygen deficit. It is believed that its sustained deficiency leads to death of individuals through a loss of biofunction, as in the case of iron deficiency.
Although oxygen is an essential molecule for maintaining life, mammals do not have a mechanism for biosynthesis of oxygen in the body [18] . Higher organisms such as vertebrates are always "deficient" in oxygen and hence have evolved to construct a mechanism to respond to hypoxia. The notion that body is able to sense hypoxic conditions and is able to actively adapt to maintain the body integrity, has gained importance [19, 20] . Oxygen concentration in the cell is maintained within a relatively narrow range and homeostasis is established. In humans, the alveolar partial pressure is approximately 110 mmHg and oxygen partial pressure in the heart, kidney and brain is approximately 20 mmHg. The physiological oxygen concentration of all cells is determined by the supply and consumption of oxygen. The cells either overcome or adapt in order to survive adverse conditions, such as oxygen deficiency (hypoxia state) and oxygen excess (high oxygen state) [19, 20] .
Higher multicellular organisms that have an anatomically complex configuration have a specialized mechanism to allow all cells to acquire necessary and sufficient amounts of oxygen. The respiratory system is composed of the lungs, diaphragm, respiratory support muscles, and neuroepithelial cells, which sense the partial pressure of oxygen, and provide a site for oxygen to bind to hemoglobin in the erythrocytes. The cardiovascular system is composed of red blood cells, which are the oxygen-conveying media; heart, which is a conveying engine; and blood vessels, which are the conveying pathways. For proper development and maintenance of these systems, harmonious expression of thousands of genes is necessary [19] .
Exploration of erythropoietin (EPO) production induction mechanism
It is reported that established human cell lines, derived from human liver cancer, produce EPO in response to hypoxia [21, 22] . It was found that EPO, which was thought to be produced in special cells or renal erythropoietin-producing cells (REP cells) in the kidney stroma, also can be produced in a cell line capable of growing indefinitely on a petri dish [21] . This was the exact beginning of the modern era in hypoxia biology [22, 23] . Later, a transcription factor that is responsible for EPO induction was isolated and the molecular mechanism of hypoxia-inducible EPO in cultured cells was almost elucidated [24] [25] [26] . Identification of genetic regions involved in the induction of EPO expression by hypoxia, and molecular cloning and activation of the intracellular factor, hypoxia-inducible factor 1 (HIF-1), further expanded knowledge in this area. Comparison of cDNAs encoding human, mouse, and rat HIF-1α revealed 90% amino acid sequence identity [27] [28] [29] [30] .
In mammals, three genes have been shown to encode HIF-α subunits that appear to be regulated in a similar manner [31] [32] [33] . The HIF-1α protein is ubiquitously expressed throughout the tissues, whereas its paralogs, HIF-2α (also known as endothelial PAS domain protein 1 (EPAS1), HIF-1-like factor, HIF-related factor, and member of PAS superfamily 2) and HIF-3α, have more restricted expression patterns [34] . RNA expression examined by in situ hybridization of mouse embryos revealed that the expression of HIF-2α is more restricted and is particularly abundant in blood vessels [35] . This observation led to the hypothesis that the primary role of HIF-2α is to modulate vascular endothelial cell function, an idea that is supported in part by the close correlation of the mRNA expression patterns of HIF-2α and vascular endothelial growth factor A. A more complex view emerged as HIF-2α protein expression was identified in multiple cell types in hypoxic rat kidney, lung, and colonic epithelia, as well as in hepatocytes, macrophages, muscle cells, and astrocytes, indicating that both HIF-1α and HIF-2α are coexpressed in many cell types. Most HIF transcriptional responses have been attributed to HIF-1α and HIF-2α; however, a third HIF-α subunit (HIF-3α) has also been described [36] . Although little is currently known about the effect of HIF-3α on tumor progression in hypoxic conditions, HIF3A mRNA has been found to be differentially Because excess levels of iron can be toxic to the body, its absorption from duodenum is limited to 1-2 mg daily, and most of the iron needed daily (about 25 mg per day) is provided through recycling by reticuloendothelial macrophages that phagocytose senescent RBCs. Iron deficiency is the reduction of iron stores that precedes overt iron-deficiency anemia. Iron-deficiency anemia is a condition in which low levels of iron are associated with anemia and the presence of microcytic hypochromic red cells. On the other hand, iron-restricted erythropoiesis indicates a reduced supply of iron for the purpose of erythropoiesis, regardless of the level of iron stores. Illustrations were quated from TogoPictureGalley (2016 DBCLS Togo TV / CC-BY-4.0).
spliced to produce multiple HIF-3α isoforms that either promote or inhibit the activity of other HIF complexes [37, 38] . On the other hand, HIF-1β is generally found to be constitutively expressed and insensitive to changes in oxygen availability, whereas the levels of the α-subunits are acutely regulated in response to hypoxia [39, 40] . Although there is evidence for hypoxic induction of HIF-1α mRNA in some cell types, the predominant O 2 -dependent regulation of HIF-1α is mediated by posttranslational mechanisms [31] .
Elucidation of oxygen sensing mechanism
HIFs comprise an α subunit (HIF-α) and a β subunit (HIF-1β), having a helix-loop-helix (HLH) and a Per-Arnt-SIM (PAS) domain, connected by a hydrophobic bond. During activation, the heterodimers are transferred to the cell nucleus, where they bind to the hypoxia response element (HRE) of the target genes to promote expression [39, [41] [42] [43] . Regulation of the intracellular protein expression of the α subunit is extremely crucial during this event. In the cultured state, where the concentration of atmospheric O 2 is maintained at 20%, the expression of HIF-1α protein is suppressed to a very low level, but the amount of protein expressed, abruptly increases in response to a decrease in the partial pressure of oxygen (5% or less) [40] . In addition, the activity (transcription activating ability) of HIF-1, as a transcription factor, rises as the oxygen partial pressure decreases, independent of the change in the protein concentration [43] . Thus, HIF-α accumulated in cells forms a dimer with HIF-1β, and the activated dimerized HIFs move to the cell nucleus and bind to the responsive elements to promote expression of the target genes. It was this understanding of the molecular biology of HIF-1 that opened avenues for research on "modern" hypoxia-sensing mechanisms [44] .
The HIF-α protein, translated from mRNA, undergoes hydroxylation modification at the prolyl residue in the presence of sufficient oxygen [45, 46] . It then undergoes ubiquitination modification, which is dependent on the hydroxylated prolyl residue, resulting in an intracellular protein destruction organization [47, 48] . Thereafter, it is carried to a proteasome, where it undergoes decomposition. However, transcriptional activation capacity of HIF-α is controlled by a hydroxylation modification of asparaginyl residue, apart from protein stabilization [49] . Under low oxygen concentration, hydroxylation of the prolyl and asparaginyl residues is inhibited, protein destruction is reduced, and HIF-α accumulates in the cell, enabling association with a basic transcription factor such as p300, leading to activation [16, 50] (Fig. 2) .
Isolation of hydroxylation-modifying enzymes (PHDs, FIH-1) of HIFα
Two types of dioxygenases or hydroxylases and the von HippelLindau (VHL) complex, along with E3 ubiquitin ligase, play the most important role in this scheme [44, 51] . For studying the oxygenated enzymes, cDNAs were isolated. Prolyl hydroxylase comprises three types of isozymes: prolyl hydroxylase domain (PHD) 1-3 [24] , and asparagynyl residue hydroxylase, also known as factor inhibiting HIF (FIH)-1 [25, 26, [52] [53] [54] . Enzymological properties were analyzed using recombinant proteins, and it was found that these enzymes have molecular oxygen, α-ketoglutarate, a prolyl or asparaginyl residue as substrate requiring divalent iron (Fe(II)), and ascorbic acid, as a coupling factor [55, 56] (Fig. 3) .
A drop in the partial pressure of oxygen signals for a decrease in the activity of the hydroxylase enzymes, and as a result, the proportion of hydroxylated products among the newly formed HIF-α decreases and associates with VHL, which is accompanied by a decrease in ubiquitination. Hence, the balance between protein destruction and neogenesis shifts, and a scheme or "dogma" in which HIF-α protein accumulates in the cell, is generated (Fig. 3 ).
Systemic iron homeostasis
The human body has sophisticated systems to conserve iron homeostasis in several ways, including the recycling of iron after the breakdown of red blood cells and the retention of iron in the absence of an excretion mechanism [12] . The body iron content and distribution is mainly carried out by five cell types: enterocytes of the small intestine, hepatocytes, erythroid cells, macrophages of the reticuloendothelium, and renal erythropoietin-producing cells. The duodenal enterocytes regulate dietary iron absorption, whereas circulating iron affects the utilization. Reticuloendothelial macrophages act as iron storage and recycling components [57] . Hepatocytes regulate iron storage and endocrine regulation. Each of these cell types play an essential role in the homeostatic iron cycle [2,5,11,58,59] (Fig. 4) . Oxygen and iron sensing by the HIF system. In well-oxygenated and iron-replete cells, prolyl hydroxylase domain 2 (PHD2) uses oxygen to hydroxylate α-subunits including HIF-1α and HIF-2α of hypoxia-inducible factor (HIF-α) on a prolyl residue (Pro-OH). The von Hippel-Lindau (VHL) protein binds to HIF-α containing Pro-OH and recruits a ubiquitin E3 ligase. The polyubiquitination of HIF-1α flags the protein for degradation by the 26S proteasome. Factor inhibiting HIF-1 (FIH-1) also uses oxygen to hydroxylate HIF-1α on an asparaginyl residue (Asn-OH). HIF-α containing Asn-OH cannot be bound by the coactivator protein p300, thereby preventing HIF-α from activating gene transcription. Under hypoxic or iron-depleted conditions, the Pro and Asn hydroxylation reactions are inhibited, and HIF-α (i.e., either HIF-1α or HIF-2α) rapidly accumulates.
Circulating serum iron
The iron from the small intestine and macrophages in serum bind to the transport protein, transferrin (Tf). The ferrous iron in serum is oxidized to the ferric form (Fe (III)) by ferroxidases such as hephaestin (HEPE) or ceruloplasmin (CP) [60, 61] . Because normal Tf saturation is low (about 30%) and Tf-binding capacity normally exceeds iron concentration in plasma, Tf-bound iron constitutes the only physiologic source available to most cells. Cells regulate the intake of Tf-bound iron by modulating the expression of Tf receptor 1 (TfR1) on the cell surface [11] .
Enterocytes of small intestine
Maintaining homeostatic balance requires the daily absorption of 1-2 mg of iron. The duodenal enterocytes are involved in dietary iron acquisition and generate iron fluxes from the tissues and cells to the plasma component [62] [63] [64] (Fig. 4A ). Non-heme dietary iron exists largely as ferric salts and is insoluble and thus, biologically unavailable in this form [65] . Therefore, Fe (III) is reduced to the soluble form Fe (II) in the proximal intestine, by duodenal cytochrome b (Dcytb), an ascorbate-dependent ferric reductase [65, 66] . In duodenal enterocytes, the reduced iron is transported through a divalent metal transporter 1 (DMT1, also known as Nramp2 and SLC11a2) [15, 60, 67] . Majority of the iron is stored in the form of ferritin and is lost when the senescent cells are disposed. Export of iron from cells to plasma occurs through the sole known iron exporter, ferroportin (FPN), highly expressed in the duodenal cells, hepatocytes, macrophages and placental cells [64, 68, 69] . It should be noted that the steps, including reduction, absorption, storage, and transfer, are regulated by signals derived from O 2 tension of enterocytes, intracellular iron levels, and systemic iron requirement. O 2 concentration of cells regulates iron absorption through its effects on the transcription factor HIF-2 (whose α subunit is HIF-2α), and subsequent changes in transcription of Dcytb, DMT1 and FPN [68] [69] [70] .
Hepatocytes
Hepatocytes are an important site of iron storage in the form of ferritin [9, 11] (Fig. 4B) . Hepatocytes can acquire Tf-Fe 2 via transferrin Heme is then exported into the cytoplasm by the heme transporter HRG-1 (SLC48A1) from phagolysosomes and processed by HMOX1 to release iron, which is either stored in ferritin or exported into the circulation via FPN with the assistance of the ceruloplasmin (CP) ferroxidase. Iron utilization by the erythroid marrow and its recycling by macrophages are regarded as the major iron fluxes in the body. (D) Renal erythropoietin-producing cells (REPs) or peritubular fibroblasts of the kidney sense lack of iron and oxygen and produce and release EPO to enhance erythropoiesis. When bound to iron and oxygen, prolyl hydroxylases (PHDs) and factorinhibiting HIF 1(FIH-1) normally trigger the degradation of the HIF-2α; iron supply to PHD2 may be facilitated by poly(rC)-binding proteins (PCBP). Low iron and/or oxygen conditions inactivate PHD2, leading to HIF-2α accumulation and stimulation of EPO transcription by HIF-2. In addition to PHDs and FIH-1, HIF-2α is translationally regulated by the IRP1/IRE system. (E) Iron acquisition in erythroid cells is dependent on endocytosis of diferric transferrin (Tf-Fe 2 ) via the transferrin receptor (TFR1). In acidified endosomes, iron is freed from Tf and exported into the cytoplasm by DMT1. The metabolically active labile iron pool (LIP) is used directly for incorporation into iron proteins or transported into mitochondria. In mitochondria, iron is inserted into protoporphyrin IX (PPIX) to produce heme. Heme is transported out of the mitochondria for incorporation into hemoproteins, mostly hemoglobin. In the cytosol, excess iron is sequestered within heteropolymers of ferritin H and L chains. Cellular iron efflux is mediated by ferroportin (FPN) and requires iron oxidation on the extracellular side.
receptor (TFR1) and solute carrier family 39, member 14 (ZIP14) [71] , respectively. Notably, hepatocytes play an essential role in iron homeostasis by production of the hormone hepcidin [72] . Hepcidin functions as an acute-phase reactant that adjusts variations in plasma iron levels caused by absorptive enterocytes and macrophages in the spleen. It binds to and induces the degradation of FPN, which exports iron from cells [68] . Hepcidin expression increases in response to high levels of iron in serum and tissues. In contrast, the induction of hepcidin is inhibited by increased erythropoiesis, iron deficiency, and tissue hypoxia, in response to signals originating in the bone marrow, liver, muscle tissue, and adipocytes.
Reticuloendothelial macrophages
Reticuloendothelial cells, including macrophages in the spleen, function as one of the major iron storage moieties [73, 74] (Fig. 4C) . The cells release 25 mg of iron daily. Since the pool of circulating Tf -bound iron is less than 3 mg, reticuloendothelial cells are the largest compartment of iron metabolism. Most of the iron in the reticuloendothelial cells is derived from the phagocytosis of senescent red blood cells. The iron can be stored in ferritin or exported into the circulation [75, 76] . Ferritin is an iron-storage protein complex composed of 24 ferritin monomers of two subtypes: heavy and light chains. The relative proportion of these ferritin chains in the complex is different between tissues. The IRE (iron responsive element)-IRP (iron regulatory protein) system increases ferritin mRNA translation in response to cellular iron concentration [4, 77] .
Erythroid precursors
Erythroid precursors are the major iron-consuming cells [78] (Fig. 4D) . These cells express high levels of TfR1. TfR1 mediates the entry of iron-bound Tf into the endosomes. On acidification of the endosomes, the iron is released into the cytoplasm as labile iron pool (LIP). The IRE-IRP system plays an important role in the functioning of the erythroid precursors [79] . It regulates the stability of the mRNA of TfR1 and translation of the mRNA for erythroid-specific 5-aminolevulinate synthase, the first enzyme in heme synthesis [80] (as for details, see below). Interestingly, the production of heme needs transferrinbound iron; non-transferrin bound iron is not used [14] .
Renal erythropoietin-producing cells
Renal erythropoietin-producing cells, which are peritubular fibroblasts of the kidney, sense iron and oxygen deficiency and release EPO to enhance erythropoiesis [81] [82] [83] (Fig. 4E) . When bound to iron and oxygen, prolyl hydroxylase 2 (PHD2) normally triggers the degradation of HIF-2α; iron supply to PHD2 may be facilitated by Poly(rC)-binding proteins (PCBP). Low iron and/or oxygen conditions inactivate PHD2, leading to HIF-2α accumulation and stimulation of EPO transcription. In addition to PHD2, HIF-2α is also translationally inhibited by IRP1 [84] .
Intracellular iron balance
At the cellular level, most cells tightly regulate the intracellular iron pool by effective control of iron up-take by tuning the expression of TfR1 and of the sequestration of intracellular free iron by modulating ferritin expression level [85] [86] [87] [88] (Fig. 4A, B and E). Ferritin is a universal intracellular protein that stores iron and releases it by an elaborate system. Ferritin serves to store iron in a non-toxic form, to deposit it in a safe form, and to transport it to organelles. The function and structure of the expressed ferritin protein varies in different cell types [86, 87] . Iron is released from ferritin for use, by ferritin degradation, which is performed mainly by lysosomes. Iron taken up by the cells, enters a cytosolic pool, as the LIP. The LIP serves as a medium for storage, export, or metabolic utilization. In the cytoplasm, elemental iron is used by diverse Fe(II)-dependent proteins, in assistance with poly(rC)-binding proteins (PCBPs)1 and 2. PCBPs act as iron chaperons, which facilitate iron loading onto the HIF-α subunit prolyl and asparaginyl hydroxylases [75, 89, 90] .
Cytosolic iron concentrations are recognized by the RNA-binding proteins (RBPs) iron-regulatory proteins 1 and 2 (IRP1 and IRP2) (Fig. 5) . IRP1 (also called aconitase 1, encoded by ACO1) is a cytosolic protein that functions as an essential enzyme in the TCA cycle and interacts with mRNA to control the intracellular iron concentration. When cellular iron levels are high, IRP1 binds to a [4Fe-4S] cluster and functions as an aconitase in the mitochondria. Aconitases are ironsulfur proteins that function to catalyze the reaction from citrate to isocitrate. When cellular iron levels are low, the protein binds to stem loop structures called iron responsive elements (IREs), which are stemloop structures found in the 5′ UTR of ferritin mRNA, and in the 3′ UTR of TfR1 mRNA. Binding of IRP1 to IRE on the 5′ UTR of ferritin mRNA consequently results in repression of translation of ferritin mRNA. In contrast, binding of IRP1 to IRE on the 3′ UTR of TfR1 mRNA results in the inhibition of degradation of transferrin receptor mRNA (Table 1) .
On the other hand, IRP2 derived from IREB2 gene, does not bind iron-sulfur clusters and apparently lacks its activity as aconitase. IRP-2 seems to be the predominant regulator of iron homeostasis in mammalian cells at physiological oxygen tensions. The proteasomal degradation of IRP2 requires 2-oxoglutarate-dependent oxygenases that utilize iron, oxygen, and ascorbate as essential cofactors, and shows remarkable similarities with respect to the degradation of HIF-α. IRP binding to IREs is regulated primarily by cellular iron availability, although the IRPs do not sense iron fluctuation directly (Table 1) .
Notably, the IRP-IRE system is not the only regulator of cellular iron homeostasis, and iron metabolism is subjected to other modes of regulation. One example is the case of FPN [68, 69] . FPN expression is regulated at several levels: transcriptional level (by BACH1/NRF2 and HIF2) [91, 92] , posttranscriptional level (through miR-485-3p), translational level (by the IRPs), and posttranslational level (by hepcidin) [93] . In addition, HIF-2α and IRPs have common target genes, including FPN and SLC11A2 (Dmt1), and HIF-2α itself is controlled by the IRPs. 
Involvement of HIFα-hydroxylase system in iron sensing
Oxygen sensing mechanism to HIF activation
The oxygen-dependent responses can be mimicked by iron chelators or cobaltous iron, indicating the involvement of ferroprotein as an oxygen sensor. In fact, initially, it was hypothesized that the putative oxygen sensor is a heme protein [23, 94] . However, this hypothesis was later rejected [24, 25, 31, 49, 52] . Instead, there is an established consensus that HIF-α protein stability is regulated through posttranslational hydroxylation of specific prolyl residues (Fig. 4) . The activity of HIFs is largely regulated by two types of hydroxylases, PHDs and FIH-1 [24, 25] . Hydroxylation is catalyzed by specific oxygen-dependent enzymes that belong to the 2-oxoglutarate-dependent dioxygenase superfamily [55, 56] . These are non-heme, Fe(II)-dependent enzymes, in which the iron is loosely coordinated by a two-histidine-one-carboxylate facial triad at the catalytic center, accounting for the ability of iron chelators to inhibit enzyme activity. The enzymes catalyze the reaction of both, hydroxylation of HIF-α and oxidative decarboxylation of 2-oxoglutarate to succinate and carbon dioxide. In the absence of HIF-α as substrate, uncoupled turnover leaves the iron center in an oxidized and inactive form. Ascorbate is required for full catalytic activity and likely functions to reduce the iron center in this enzymatic reaction. To study the details of the catalytic properties of the enzymes, all three human PHDs and FIH-1 enzymes were expressed as recombinant proteins in insect cells, using an assay based on the measurement of 14 CO 2 released during the hydroxylation-coupled decarboxylation of 2-oxoglutarate, adopting methods similar to those used for collagen prolyl 4-hydroxylase (C-P4H) [55, 56] (Table 2) .
Iron-sensing mechanism for activation of HIFs
In the HIFα-hydroxylation reaction, oxygen serves as a substrate and Fe(II), a cofactor. It is well known that the iron chelator, deferoxamine mesylate, is a potent inducer of HIFs [24, 26, 52] (Fig. 3) ( Table 2) . Thus, iron concentration plays an essential role in the activity of HIFs, as well as regulating oxygen concentration. A classical study indicates that continuous hypoxemia induces a very early increase in iron absorption within 8 h after the onset of hypoxia [95] . This increase precedes alterations in serum or plasma levels of iron, erythropoiesis, or hepcidin and is due to increases in the mucosal uptake of iron [95, 96] . HIFs acting as local sensors of enterocyte oxygen, provide an explanation for this early response.
Decrease in tissue oxygen concentration in the kidney, as a consequence of either systemic hypoxemia or anemia, activates HIFs, resulting in increased EPO production. EPO is the most important gene in iron homeostasis. Because the process of erythropoiesis consumes iron massively, enhanced input of EPO signal and subsequent erythropoiesis alone would rapidly lead to a state of cellular iron deficiency. Thus, iron and its deficiency are the most common limiting factors in erythropoiesis. Therefore, efficient erythropoiesis absolutely requires the coordinated supply of iron to meet the demand. The transcription factors HIFs, including HIF-1 and HIF-2 [97] , induce upregulation of the expression of both, the iron transporter molecule Tf, and its cellularuptake acceptor, the transferrin receptor 1 (TfR1) as well as the IRP-IRE interaction [98] . Because only Fe(III) can be bound by transferrin, ceruloplasmin, which is required to oxidize Fe(II) to Fe(III), also is important in iron transport. In addition, ferrochelatase [99, 100] , the enzyme that catalyzes insertion of Fe(II) into heme molecules, is also a target gene of HIF. The major proportion of iron required for essential protein synthesis is derived from the turnover and recycling of heme proteins. Heme oxygenase catabolizes conversion of heme to biliverdin, with the release of free iron. Among the subtypes of heme oxygenase, heme oxygenase 1 (HO-1 and HMOX1) is also under HIF transcriptional control and facilitates recycling of iron during hypoxia [101] .
Relative iron deficiency generated by EPO-driven red cell production would act to suppress hepcidin production and to enhance ferroportin-mediated intestinal iron absorption. However, recent evidence suggests additional mechanisms, by which HIF is able to regulate hepcidin more directly. HIF can bind hypoxia-response elements (HRE) in the hepcidin promoter and suppress hepcidin expression directly [70] . Furin, a proprotein convertase, is identified as a HIF target gene. With increased levels of furin in hypoxia, there is an increase in sHJV, which also reduces the expression of hepcidin. These new links between the HIF pathway and hepcidin regulation, provide additional mechanisms for coordinate upregulation of both erythropoietin and ferroportin, further supporting erythropoiesis by allowing the HIF pathway to enhance iron metabolism.
In addition, duodenal uptake from the intestinal lumen into the enterocyte involves reduction of Fe(III) to Fe(II) by the apical ferric reductase duodenal cytochrome b (Dcytb), followed by uptake by the apical iron transporter divalent metal transporter-1 (DMT1). Both the proteins have recently been demonstrated to be direct HIF-2α target genes. 
HIF target genes
Following are more detailed descriptions of the key molecules and HIFs (Table 3 ).
Hepcidin
Hepcidin, also called as hepcidin antimicrobial peptide or HAMP, a small antimicrobial peptide expressed in the liver, plays an essential role in the maintenance of iron homeostasis [72, 93, 102, 103] . It is necessary for the regulation of iron storage in macrophages, and for intestinal iron absorption. A line of studies clearly indicates that hepcidin is deeply involved in the three components of in vivo iron regulation: systemic iron status, iron requirement for erythropoiesis, and inflammation. Hepcidin-knockout mice develop iron overload in the liver and pancreas, and an iron deficit in the macrophage-rich spleen. Accordingly, transgenic animals with hepcidin gene over-expression cannot survive due to severe iron deficiency. Hepcidin is a spliced protein from its preproprotein form. The preproprotein form is posttranslationally cleaved into mature peptides of 20, 22, and 25 amino acids, and these active peptides are rich in cysteines, which form intramolecular bonds that stabilize their β-sheet structures. Interestingly these spliced peptides exert antimicrobial activity against bacteria and fungi. Hereditary hemochromatosis can result from hepcidin deficiency attributed to specific mutations in at least 4 distinct genes, including the hepcidin gene (HAMP) itself, in humans [6, 104, 105] .
Hepcidin expression is regulated by oxygen tension, iron signals, erythropoiesis, and inflammation [106] . Hypoxia reduces hepcidin expression, both in vivo and in tissue culture. Mice subjected to hypoxia exhibited reduced hepcidin levels and increased iron uptake [70] . In addition, in vitro experiments demonstrate that hypoxia decreases expression of hepcidin mRNA in cultured cells [59] . Hepcidin is strongly induced during infections and inflammation, causing intracellular iron sequestration and decreased plasma iron levels, consequently triggering the "anemia of chronic disease" [11, 103, 107, 108] .
Furin
Furin is a member of proprotein convertases. The iron-regulatory peptide hepcidin is synthesized in the liver as an 84-aa pre-pro-hormone, matured by proteolysis through a consensus furin cleavage site, to generate the bioactive 25-aa peptide secreted in circulation. This peptide regulates iron export from enterocytes and macrophages, by binding the membrane iron exporter, ferroportin, leading to its degradation. Whether pro-hepcidin could be secreted and be reflected in hepcidin levels, remains an open question. In addition, soluble HJV(s-HJV) originates from a furin cleavage, at position 332-335. s-HJV is reduced in the cleavage mutant R335Q as well as in cells treated with a furin inhibitor, and increased in cells overexpressing exogenous furin, but not in cells overexpressing an inactive furin variant [109] . Furin is up-regulated by iron deficiency and hypoxia in association with the stabilization of HIF-1α [110] [111] [112] . Increased s-HJV in response to HIF-1α occurs during differentiation of murine muscle cells expressing endogenous Hjv.
Ferroportin
Ferroportin (FPN1, FPN) also called as solute carrier family 40 member 1(SLC40A1), is the only known cellular iron exporter; ferroportin is the only protein forming the gateway through which iron can exit cells to enter the plasma [69, 72] . Expression of FPN is well observed in cells and tissues associated with iron transport: duodenal enterocytes, liver Kupffer cells and splenic macrophages, and periportal hepatocytes [69] . FPN transports Fe(II) before iron can bind Tf. FPN was also identified as a receptor of hepcidin in cell culture experiments, where hepcidin was found to bind to ferroportin [93, 113] . After binding to hepcidin, FPN was found to be internalized and degraded in lysosomes, resulting in decreased export of cellular iron. The posttranslational regulation of FPN by hepcidin forms a homeostatic loop; iron regulates the secretion of hepcidin, which in turn controls the concentration of FPN on the cell surface [93, 113] . Mouse studies indicated that the knockout of ferroportin gene is embryonic lethal because of the inability to transfer iron from the mother to the embryo [69] . The major hepcidin-producing organ is the liver; when iron stores are adequate or high, the liver secretes hepcidin, which circulates to the small intestine. Hepcidin inhibits the transport of dietary iron to plasma transferrin by degrading FPN from the basolateral membrane of absorptive enterocytes. When iron stores are low, hepcidin production is suppressed. FPN molecules are displayed on the basolateral membranes of enterocytes, and iron is transported to plasma transferrin. Similarly, in macrophages and recycling aged RBCs, degradation of FPN by hepcidin results in the trapping of iron [93] .
In iron-recycling macrophages, erythrophagocytosis of both heme and iron increases FPN production. Heme regulates FPN transcriptionally by the Bach1/Nrf2 complex: heme causes degradation of repressor Bach1, resulting in the stimulation of FPN transcription by Nrf2 [91, 92] . Iron regulates FPN translationally by modulating the interaction of IRPs with IREs in the 5' UTR of FPN; iron prevents IRPs from binding to FPN mRNA, allowing translation to proceed [72] .
Transferrin (Tf) and transferrin receptor
Iron is required for heme synthesis in the mitochondria of erythroblasts. Distinct positive and negative regulatory elements, located 5′ to the transcription initiation site, explain tissue-specific expression of transferrin (Tf) gene. Transferrins are iron-binding blood plasma glycoproteins that control the level of free iron in plasma. Human transferrin is encoded by the TF gene, of which expression is induced in response to exposure to hypoxia. Within the enhancer region of 5′ in Tf promoter-enhancer location, a 32-base pair hypoxia-responsive [136] element was identified, which contained two HIF-1-binding sites [97, 114] . Thus, low iron can induce Tf expression by activating HIF-1. In contrast, the situation is different in the case of Tf receptor 1 (TfR1, TFRC). There is a consensus that under low intracellular iron concentration, IRPs bind transferrin receptor mRNA through direct interactions with several IRE motifs in the 3′-UTR, and that stabilizes the mRNA [4, 115] . The stability of IRPs is also regulated by O 2 tension and iron concentration and hence, it is also regulated by HIFs. In addition, TfR gene transcription is stimulated by hypoxia, and an HIF-1-binding site in the TfR promoter is involved in this response [59, 97] . Therefore, TfR1 is transcriptionally regulated by the HIF-1/HRE system and posttranscriptionally regulated by the IRP1/IRE system. Moreover, IRP1 is regulated by the HIF-1/HRE system under hypoxia. Previous studies have demonstrated that treatment with the iron chelator, DFX, results in inhibition of PHD activity, induction of HIF-1α stabilization, and induction of HIF-1-downstream gene expression, such as HO-1, TfR, Tf, ferrous ion membrane transport protein DMT1 and duodenal cytochrome b (Dcytb) [63, 84, 101] . Divalent metal transporter 1 (DMT1) and Dcytb are among the genes most highly upregulated by lack of both, iron and oxygen in the duodenum. DMT1 contains a 3′-IRE [84, 116] . In contrast, Dcytb does not have a recognizable IRE [65] , and hence, its strong regulation by iron and hypoxia has always been unexplained.
Ceruloplasmin (Cp)
Ceruloplasmin (Cp) is a 132-kDa copper serum protein. Cp is critically involved in iron metabolism. Cp is a ferroxidase and catalyzes the conversion of Fe(II) to Fe(III) in plasma [117] . This is a critical step for loading of iron onto apo-transferrin, which binds only Fe(III). Thus, Cp is deeply involved in iron transport and homeostasis. Cp functions as a facilitator of the net flux of iron between cells and tissues. Iron deficiency or hypoxia was found to increase luciferase activity of luciferase reporter in a 4774-base pair segment of the Cp promoter/enhancer region in HepG2 and Hep3B cells. The involvement of hypoxia-inducible factor-1 (HIF-1) was demonstrated by gel-shift experiments that showed HIF-1 binding to a radiolabeled oligonucleotide, containing the Cp promoter HRE. These results are consistent with in vivo findings that iron deficiency increases plasma Cp and provides a molecular mechanism that may help to understand these observations [117] . The studies show that Cp is a member of the growing family of genes, transcriptionally activated by HIF-1 [2] .
Heme oxygenase-1 (HO-1)
Heme oxygenase (HO) is an enzyme that catalyzes the degradation of heme protein [118] . The enzymatic reaction produces biliverdin, ferrous iron, and carbon monoxide. So far 3 isoforms of HO are reported [118, 119] . Heme oxygenase 1 (HO-1) is an isoform, inducible in response to stress such as oxidative stress, hypoxia, heavy metals and cytokines. Heme oxygenase 2 (HO-2) is a constitutive isoform that is expressed under homeostatic conditions. HO-1 is encoded by the HMOX1 gene and HO-2 by HMOX2 [119] . It is reported that HO-3 is not catalytically active. However, further details are yet to be investigated [120] . The expression of HO-1 is regulated by oxygen concentration. Exposure to hypoxia has been shown to induce the expression of HO-1 mRNA in a HIF-1-dependent manner [101, 121] .
Ferrochelatase
Ferrochelatase (FECH) is the last enzyme of the heme biosynthetic pathway. FECH catalyzes the insertion of iron into protoporphyrin to form heme. FECH is synthesized in the cytoplasm as a 43-kDa protein that is proteolytically processed to 40 kDa as it is translocated into the mitochondrion. Although FECH is particularly important in the terminal stages of RBC differentiation, it is expressed in almost all cell types to supply heme required for essential hemoproteins. A genetic disorder that causes a reduction in FECH activity results in erythropoietic protoporphyria in humans. FECH gene expression is induced in response to exposure to hypoxic conditions. In fact, the induction is regulated by HIF-1 [99, 100] . There are two HRE motifs within the 150 bp FECH minimal promoter sequence. In addition, regulation by microRNA is also reported. MicroRNA-210 (miR-210) increases in hypoxia and regulates mitochondrial respiration through modulation of iron-sulfur cluster assembly proteins (ISCU1/2) that are involved in Fe/S cluster synthesis. miR-210 has been shown to reduce cellular heme levels and the activity of mitochondrial and cytosolic heme-containing proteins by modulating ferrochelatase (FECH), the last enzyme in heme biosynthesis [122] .
Differential effects of HIF-1α and HIF-2α on iron regulation
HIF-1α or HIF-2α is a subunit of HIF-1 or HIF-2, respectively. HIF-1α and HIF-2α are very similar to each other, and a line of studies revealed that either HIF-1α or HIF-2α could regulate the expression of many of the same hypoxia-induced genes. However, HIF-1 or HIF-2 also has its own list of unique gene targets [123] . Experiments with chromatin immunoprecipitation assay coupled to tiled microarrays (ChIPchip) revealed that the expression of differential genes is independently regulated by HIF-1 or HIF-2.
Although HIF-1 was originally identified to have binding ability to the erythropoietin enhancer in HeLa cells, it came to light that renal erythropoietin-producing cells predominantly express HIF-2α and that HIF-2 is mainly responsible for erythropoietin regulation in response to hypoxia and anemia [83, 123] .
Another striking example is the case of hepcidin, Dcytb and DMT1 [63, 64] . The marked suppression of hepcidin is observed in conditional knockout of VHL in the liver, in which both HIF-1α and HIF-2α are stabilized. A study with conditional knockout of HIF-1α or HIF-2α indicates that transcription factor HIF-2 may play a dominant role in downregulation of hepcidin by HIFs under conditions of iron deficiency. Furthermore, both Dcytb and DMT1, which are involved in apical uptake of iron into the enterocytes, are HIF-2α target genes. Together, this is consistent with a predominant role of HIF-2α in coordinated erythropoiesis [74] .
Other forms of differential translational control have been reported for HIFα proteins. For example, the iron response element (IRE) binding protein 1 was shown to bind a canonical IRE in the 5′ untranslated region (UTR) of EPAS1 (HIF-2α), thereby inhibiting its translation [74, 84] . This effect seems to be specific for HIF-2α, as IREBP1 fails to bind the HIF1A transcript or regulate its translation, despite the presence of a near consensus IRE in the 5′ UTR of HIF1A. This regulation is also consistent with the identification of HIF-2α as the primary regulator of erythropoiesis and cellular iron metabolism in vivo.
Crosstalk between oxygen and iron metabolism on gene expression regulated by HIFs
Cellular iron concentration can be sensed by individual cells, and the signals change the activity of IRPs, as previously described [77, 124] . There is another example of the cross talk between oxygen and iron metabolism: alteration of oxygen and iron metabolism can be sensed by the protein F-box/LRR-repeat protein 5 (FBXL5) [125] [126] [127] (Fig. 6) . This gene encodes a member of the F-box protein family, which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex, called SCFs (SKP1-cull-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class, and in addition to an F-box, contains several tandem leucine-rich repeats. FBXL5 senses iron through a well-conserved hemerythrin domain from bacteria and invertebrates. Iron and oxygen bind the hemerythrin domain of FBXL5 and then the FBXL5 is stabilized, escaping degradation. On the other hand, a lack of iron or oxygen results in degradation of FBXL5. In addition, intriguingly, the carboxyl-terminal domain of FBXL5, which contains the leucine-rich repeats, binds to IRPs.
Thus, the concentrations of iron and oxygen in mammalian cells determine the stability of FBXL5, which consequently determines whether IRPs are degraded by the ubiquitin (Ub)-proteasome system or kept available to control the expression of target mRNAs.
Conclusion
We propose that HIFs, including HIF-1 and HIF-2, act both as an iron sensor and iron regulator (Fig. 7) . In this model, anemia causes decreased tissue oxygenation, as well as decreased prolyl-and asparaginyl-hydroxylase activity, and decreased VHL-mediated degradation of a subunit of HIFs. Increased HIF activity, by simultaneously regulating hepcidin, transferrin, TfR, ceruloplasmin, HO-1, ferroportin and EPO expression, allows a very efficient orchestrated response to restore normoxic conditions. HIF activation permits the rapid mobilization of iron from macrophages and enterocytes necessary for the increased erythropoietic activity, triggered by erythropoietin release from renal EPO producing cells. VHL/HIF supports production of properly formed mature erythrocytes, correcting anemia. As anemia is corrected, normalization of iron and tissue oxygen promotes HIF degradation, acting as a checkpoint on the system. HIF-target gene expression returns to normal if iron is present. If iron is deficient, HIF remains stabilized and HIF target gene expression is maintained at a low rate, ensuring increased intestinal iron absorption until stores are replete. The responsiveness of the HIF pathway to intracellular iron, the frequent observation of high levels of HIF in human cancer, and the importance of HIF to in vivo tumorigenesis raises important questions on the contribution of altered intracellular iron to these processes. Furthermore, altered iron status could potentially contribute, through perturbation of HIF, to more global responses to hypoxia, such as pulmonary hypertension. Thus, manipulation of global or local iron metabolism in these circumstances could provide potentially novel therapeutic strategies.
HIF-2α-specific inhibitors have been characterized and may be useful for treatments in iron overload diseases, and several PHD inhibitors that activate HIF-2α are under preclinical or clinical investigation for potential therapeutic use in the treatment of iron-related diseases [128, 129] . It is also important to learn more about the new generation of HIF modulators, to determine whether they are effective therapeutics for iron-related disorders. Simultaneously FBXL5 determines whether IRPs are degraded by the ubiquitin (Ub)-proteasome system, including Skp1-Cul1 E3 ligase or kept available to control the expression of target mRNAs which have IREs on their regulatory regions. These mRNAs encode proteins important in cellular iron homeostasis, including ferritin and the transferrin receptor. FBXL5 has an oxygen-bridged diiron binding site within a conserved hemerythrin domain. IRPs have amino acid-motifs that can be targets for FBXL5. Interestingly, this is very similar system to the HIF-α-hydroxylase system. Fig. 7 . The intimate interplay between iron homeostasis and oxygen metabolism. HIFs play a central role in coupling iron sensing to iron regulation. Lack of oxygen and iron lead to decreased activity of prolyl-and asparaginyl-hydroxylases, which serve as sensors of both oxygen and iron. Activated HIFα promotes decreased hepcidin and increased transferrin, transferrin receptor, ceruloplasmin, heme-oxygenase-1 (HO-1) and ferroportin, thereby promoting intestinal iron absorption, transport, oxidation, recycling and export of iron respectively. By coordinating iron availability and erythropoietin (EPO)-induced erythropoiesis, the HIF system produces complete red blood cells, correcting anemia. Normalization of iron and tissue oxygenation acts to reduce hepatic HIF-1 levels as a feedback regulation on the system. Thus, HIFs serve a pivotal and essential role in the intimate interplay between iron homeostasis and oxygen metabolism.
